These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1558179)

  • 1. Specific esponse to 5-HT2 agonists by arterioles linked to Meth A tumors in mice.
    Stücker O; Vicaut E; Teisseire B
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H704-9. PubMed ID: 1558179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific response of mouse tumor-feeding arterioles to stimulation by 5-HT1 agonists.
    Stücker O; Laemmel E; Teisseire B; Vicaut E
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1125-31. PubMed ID: 9169822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-responsiveness to 5-HT2 agonists by tumour-linked arterioles in mice: consequences for tumor growth.
    Stücker O; Vicaut E; Teisseire B
    Int J Radiat Biol; 1991; 60(1-2):237-41. PubMed ID: 1677977
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of endothelial factors in the specific response of mouse tumour-feeding arterioles to stimulation of 5-HT1 receptors.
    Laemmel E; Stücker O; Vicaut E
    Int J Radiat Biol; 1999 Mar; 75(3):365-71. PubMed ID: 10203186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
    Heller WA; Baraban JM
    Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mediation of microvascular responses to serotonin in striated muscle.
    Alsip NL; Harris PD
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1525-33. PubMed ID: 1951740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
    Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Life Sci; 1990; 47(22):2009-19. PubMed ID: 2273941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy.
    Zhang L; Dyer DC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1236-44. PubMed ID: 2359025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2 receptors in the nucleus tractus solitarius: characterisation and role in cardiovascular regulation in the rat.
    Merahi N; Orer HS; Laguzzi R
    Brain Res; 1992 Mar; 575(1):74-8. PubMed ID: 1504784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
    Glennon RA; Titeler M; Lyon RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the specific response to serotonin of mouse tumour-feeding arterioles.
    Laemmel E; Stücker O; Darmon PL; Vicaut E
    Int J Radiat Biol; 1998 Sep; 74(3):379-86. PubMed ID: 9737540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of serotonergic receptors mediating contraction of ovine umbilical artery.
    Zhang LB; Dyer DC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):233-9. PubMed ID: 2213559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
    Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
    Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Bondarev ML; Khorana N; Young R; May JA; Hellberg MR; McLaughlin MA; Sharif NA
    J Med Chem; 2004 Nov; 47(24):6034-41. PubMed ID: 15537358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vasocontractive action of norepinephrine and serotonin in deep arterioles of rat cerebral gray matter.
    Takahashi R; Sakai T; Furuyama Y; Kondo Y; Inoue CN; Onuma S; Iinuma K
    Tohoku J Exp Med; 2000 Feb; 190(2):129-42. PubMed ID: 10770621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.